Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cytokinetics
Biotech
Cytokinetics doesn't want Big Pharma help to overtake Camzyos
For a biotech planning to commercialize its first drug—and without Big Pharma backing—the company's CEO Robert Blum is keeping his cool.
James Waldron
Nov 18, 2025 1:30pm
Jefferies London conference earns reputation as 'JPM for Europe'
Nov 18, 2025 10:00am
Cytokinetics’ ph. 3 cardio win sends stock soaring
Sep 2, 2025 2:05pm
FDA pushes back Cytokinetics' heart drug PDUFA to year-end
May 2, 2025 7:48am
Sanofi scoops up China rights to Cytokinetics' heart disease med
Dec 20, 2024 11:07am
Edgewise unveils promising early data for heart disease drug
Sep 20, 2024 4:00am
